SYST-20 TARGETED THERAPY MATCHED TO GENOMIC ALTERATIONS (BRAFV600E, NTRK, FGFR, ROS1, PIK3CA, PTEN) IN PATIENTS WITH RECURRENT IDH WILDTYPE GLIOBLASTOMA: A REAL-LIFE COHORT ANALYSIS FROM VENETO INSTITUTE OF ONCOLOGY, PADUA (ITALY)

We retrospectively analyzed 34 patients (pts) [19 males, 15 females, median age 54] with recurrent IDH wildtype glioblastoma treated with target therapy (TT) based on their next-generation sequencing (NGS) profile, between March2020 and December2022 at Veneto Institute of Oncology, Padua (Italy). EC...

Descripción completa

Detalles Bibliográficos
Autores principales: Padovan, Marta, De Toni, Chiara, Maccari, Marta, Bosio, Alberto, Cerretti, Giulia, Caccese, Mario, Corrà, Martina, Vizzaccaro, Salvatore, Cestonaro, Ilaria, Pittaro, Alice, Guerriero, Angela, Coppola, Marina, Lombardi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Systemic Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402370/
http://dx.doi.org/10.1093/noajnl/vdad070.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402370/
http://dx.doi.org/10.1093/noajnl/vdad070.123

Ejemplares similares